Skip to main content
CVIR Endovascular

Table 1 Baseline patient characteristics

From: Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression

Age (y)

63 (56–75)

Gender

 • Male

19 (51)

 • Female

18 (49)

Cancer Diagnosis

 • Prostate

8 (21.6)

 • Gynecologic

9 (24.3)

 • Colorectal

3 (8.1)

 • Renal

4 (10.8)

 • Urinary Bladder

3 (8.1)

 • Othera

10 (27.1)

Level of compression

 • Inferior Vena Cava

6 (16.2)

 • Iliocaval

8 (21.6)

 • Iliac

20 (54.1)

 • Iliofemoral

3 (8.1)

Presenting Symptoms

 • Unilateral Swelling

23 (62%)

 • Bilateral Swelling

14 (38%)

 • Lower extremity Pain

11 (30%)

 • Otherb

4 (11%)

Presence of DVT

 • None

16 (43.2)

 • Bland thrombus

19 (51.4)

 • Tumor thrombus

2 (5.4)

Pre-procedure AC

 • None

16 (43.2)

 • Enoxaparin

12 (32.4)

 • Heparin drip

2 (5.4)

 • Otherc

7 (19)

  1. Statistics shown are median (IQR: interquartile range) or n(%)
  2. aOther cancers included Breast, Chondrosarcoma, Hepatocellular, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Penile SCC, Sarcoma, PEComa
  3. bOther symptoms included itching, redness, cramping, venous ulcers, varicosities
  4. cOther anticoagulants included Fondaparinux (2), Apixaban (3), Rivaroxaban (2)
Back to article page